Cost-Effectiveness Analysis of Daclizumab Beta In The Treatment of Relapsing Remitting Multiple Sclerosis In Italy

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1947
https://www.valueinhealthjournal.com/article/S1098-3015(17)32281-7/fulltext
Title : Cost-Effectiveness Analysis of Daclizumab Beta In The Treatment of Relapsing Remitting Multiple Sclerosis In Italy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32281-7&doi=10.1016/j.jval.2017.08.1947
First page : A723
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1774
Categories :
Tags :
Regions :
ViH Article Tags :